Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin

被引：0
|
作者：
Elisabeth E. Fransen van de Putte
Laura S. Mertens
Richard P. Meijer
Michiel S. van der Heijden
Axel Bex
Henk G. van der Poel
J. Martijn Kerst
Andries M. Bergman
Simon Horenblas
Bas W. G. van Rhijn
机构：
[1] The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Urology
[2] University Medical Center Utrecht,Department of Urology
[3] The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
来源：
World Journal of Urology | 2016年 / 34卷
关键词：
Bladder cancer; Neoadjuvant chemotherapy; Dose dense; MVAC; Cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：157 / 162
页数：5
相关论文
共 50 条
  • [21] Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer
    Voskuilen, Charlotte S.
    van der Heijden, Michiel S.
    van Rhijn, Basw. G.
    EUROPEAN UROLOGY, 2019, 76 (06) : 870 - 871
  • [22] THE EFFICACY OF GC VERSUS MVAC CHEMOTHERAPY REGIMEN FOR MUSCLE-INVASIVE BLADDER CANCER
    Liu, Liwei
    Liu, Chunyu
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A214 - A214
  • [23] Downstaging of Muscle-Invasive Bladder Cancer Using Neoadjuvant Gemcitabine and Cisplatin or Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as Single Regimens or as Switch Therapy Modalities
    Ruplin, Andrew T.
    Spengler, Anne M. Z.
    Montgomery, Robert B.
    Wright, Jonathan L.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (05) : E557 - E562
  • [24] Dose-dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for patients with muscle-invasive bladder cancer (MIBC): Results of the GETUG/AFU VESPER V05 phase III trial
    Pfister, C.
    Gravis, G.
    Flechon, A.
    Chevreau, C. M.
    Mahammedi, H.
    Laguerre, B.
    Guillot, A.
    Joly, F.
    Soulie, M.
    Allory, Y.
    Harter, V.
    Culine, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S678 - S678
  • [25] SAFETY AND EFFICACY GEMCITABINE-CISPLATIN SPLIT DOSE AS A NEOADUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
    Abdelhafez, Mohamed
    Williams, Michael
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1194 - E1194
  • [26] Pathologic down-staging following standard (SD) MVAC (methotrexate-vinblastine-doxorubicine-cisplatin) or dose-dense MVAC (DD) neoadjuvant chemotherapy (NC) for muscle-invasive urothelial bladder cancer (UC): A An retrospective multicenter cohort of the French Genitourinary Look Tumor Group (GETUG/AFU).
    Pouessel, Damien
    Chevret, Sylvie
    Bompas, Emmanuelle
    Boudin, Laurys
    Joly, Charlotte A.
    Grellety, Thomas
    Terrisse, Safae Aarab
    Boyle, Helen Jane
    Roubaud, Guilhem
    Chevreau, Christine
    Dauba, Jerome
    Moriceau, Guillaume
    Alexandre, Ingrid
    Deplanque, Gael
    Chapelle, Angelique
    Vauleon, Elodie
    Colau, Alexandre
    Audenet, Francois
    Culine, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Phase II study of neoadjuvant chemotherapy with four cycles of dose-dense MVAC followed by radical cystectomy in Korean patients with muscle-invasive or locally advanced urothelial carcinoma of bladder
    Park, Kwonoh
    Lee, Hyun Jung
    Kim, Tae Un
    Ryu, Hwaseong
    Ki, Yong Kan
    Hong, Yun Jeong
    Nam, Jong Kil
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 739 - 746
  • [28] Neoadjuvant accelerated MVAC (AMVAC) in patients with muscle invasive bladder cancer: Results of a multicenter phase II study
    Plimack, Elizabeth R.
    Hoffman-Censits, Jean H.
    Viterbo, Rosalia
    Greenberg, Richard Evan
    Chen, David
    Lallas, Costas D.
    Trabulsi, Edouard John
    Wong, Yu-Ning
    Kutikov, Alexander
    Lin, Jianqing
    Duncan, Gail
    Adair, Beth
    Cione, Charlotte
    O'Sullivan, Conor
    Kilpatrick, Deborah
    Ross, Eric A.
    Boorjian, Stephen A.
    Uzzo, Robert G.
    Kelly, William Kevin
    Hudes, Gary R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] NEOADJUVANT ACCELERATED MVAC IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER: A MULTI-INSTITUTIONAL PROSPECTIVELY ACCRUED COHORT
    Mehrazin, Reza
    Plimack, E.
    Kutikov, A.
    Tomaszewski, J.
    Hoffman-Censits, J.
    Viterbo, R.
    Greenberg, R.
    Ginzburg, S.
    Corcoran, A.
    Lallas, C.
    Trabulsi, E.
    Wong, Y-N.
    Boorjian, S.
    Smaldone, M.
    Uzzo, R.
    Chen, D.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E214 - E214
  • [30] High Rate of Complete Remission (CR) Using Two Sequential, Dose-dense Regimens of Cisplatin, Gemcitabine, and Paclitaxel (CGP) Followed by HD-MVAC in Patients With Metastatic Bladder Cancer (mBC)
    Brighenti, M.
    Passalacqua, R.
    Arnaudi, R.
    Potenzoni, M.
    Donini, M.
    Liguigli, W.
    Poll, R.
    Lazzarelli, S.
    Panni, S.
    Curti, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S516 - S516
12345